A breast cancer researcher at Kansas State University has received a $1.2 million federal grant.
Anna Zolkiewska will use the four-year grant from the National Institutes of Health's National Cancer Institute to conduct research aimed at improving cancer survival rates.
The associate professor of biochemistry and molecular biophysics is focused on breast tumor initiating cells, also called cancer stem cells. These cells drive breast tumor progression and tumor recurrence or metastasis.
Current treatments for breast cancer, such as surgery, chemotherapy and radiation therapy, can destroy the majority of tumor cells. But these treatments cannot eradicate cancer stem cells.
Zolkiewska says it's critical to find more effective treatments against them.